Cite
Duffaud F, Even C, Ray-Coquard I, et al. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients. Clin Sarcoma Res. 2012;2(1):11doi: 10.1186/2045-3329-2-11.
Duffaud, F., Even, C., Ray-Coquard, I., Bompas, E., Khoa-Huynh, T., Salas, S., Cassier, P., Dufresne, A., Bonvalot, S., Ducimetiere, F., Le Cesne, A., & Blay, J. Y. (2012). Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients. Clinical sarcoma research, 2(1), 11. https://doi.org/10.1186/2045-3329-2-11
Duffaud, Florence, et al. "Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients." Clinical sarcoma research vol. 2,1 (2012): 11. doi: https://doi.org/10.1186/2045-3329-2-11
Duffaud F, Even C, Ray-Coquard I, Bompas E, Khoa-Huynh T, Salas S, Cassier P, Dufresne A, Bonvalot S, Ducimetiere F, Le Cesne A, Blay JY. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients. Clin Sarcoma Res. 2012 Sep 05;2(1):11. doi: 10.1186/2045-3329-2-11. PMID: 22950685; PMCID: PMC3502564.
Copy
Download .nbib